Resources
About
Events
Upcoming Events
Archived Events
Newsletter
Bloody Easy E-Tools & Publications
Bloody Easy Blood Administration (BEBA)
Bloody Easy for Healthcare Professionals
Bloody Easy Lite
ORBCoN Tech Assess
Blood Utilization & Audits
Audits Tools
Blood Utilization Graphs
COPTN Reports
O Negative RBC Utilization
Provincial Audit Reports
RBC Benchmarking
STAT and ASAP Delivery Study
COVID-19
IVIG/SCIG
Ordering IG in Ontario
Utilization Management Guidelines
Dosing Using Adjusted Body Weight
Infusion Guide and Adverse Events
IG QIP
Immune Globulin Toolkit
Facts for Patients
Travelling with IG
Massive Hemorrhage Protocol
eLearning
Provincial MHP Toolkit
Supplementary Resources
Recommendation Statements
ORBCoN Resources
Helpful Apps
Interesting Podcasts
Newsletter
Order Resources
Presentation Library
Toolkits
Bedside Audit
Dispensary and Administration
Emergency Blood Management
Home Infusion Toolkit
Implementing an Evaluation Process for your Transfusion CAP
Inventory Management
New Product
OTTRM
Resources for Midwives
Special Blood Requirements
Transporting Blood Internally
Transfusion Committee
Transfusion Safety Officer Resource Manual
Quality Improvement Plan
TM Guidelines, Standards, & Recommendations
Guidelines
NAC Guidelines and Recommendations
Recommendations
Resource Manual for Medical Directors of Transfusion Medicine
Standards
Quality Improvement
Home
»
TM Guidelines, Standards, & Recommendations
»
Guidelines
»
Obstetric / Gynaecologic
»
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn
British Committee for Standards in Haematology, 2014.
Attachment:
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn
View
Download